Investments
1Portfolio Exits
1Latest Alfred I. duPont Testamentary Trust News
Jun 18, 2012
On Monday, Attorney General Beau Biden will announce how his office will help to protect Delawareans’ interest in the AI DuPont Testamentary Trust, which funds The Nemours Foundation. Last March a Florida Court approved Biden’s motion to allow Delaware to intervene in the court’s review of a request to split the Trust into 2 entities for more favorable tax treatment. This gives Biden assurance that the intentions of AI DuPont – that first consideration be given to the
Alfred I. duPont Testamentary Trust Investments
1 Investments
Alfred I. duPont Testamentary Trust has made 1 investments. Their latest investment was in La Jolla Pharmaceutical Company as part of their Unattributed VC - IV on January 1, 2002.
Alfred I. duPont Testamentary Trust Investments Activity
Date | Round | Company | Amount | New? | Co-Investors | Sources |
|---|---|---|---|---|---|---|
1/18/2002 | Unattributed VC - IV | La Jolla Pharmaceutical Company | $51.59M | Yes | AWM Investment Company, Bain Capital Public Equity, Deerfield Management, Deka Investment, DekaTeam-BioTech, East Bay Municipal Utility District, EGS Healthcare Capital Partners, ING, J.P. Morgan Chase & Co., Memorial Hospital Of South Bend, Nemours Foundation, RS Investments, Safeco, SF Capital Group, UBS, Undisclosed Investors, Utah Retirement Systems, and Zeke |
Date | 1/18/2002 |
|---|---|
Round | Unattributed VC - IV |
Company | La Jolla Pharmaceutical Company |
Amount | $51.59M |
New? | Yes |
Co-Investors | AWM Investment Company, Bain Capital Public Equity, Deerfield Management, Deka Investment, DekaTeam-BioTech, East Bay Municipal Utility District, EGS Healthcare Capital Partners, ING, J.P. Morgan Chase & Co., Memorial Hospital Of South Bend, Nemours Foundation, RS Investments, Safeco, SF Capital Group, UBS, Undisclosed Investors, Utah Retirement Systems, and Zeke |
Sources |
Alfred I. duPont Testamentary Trust Portfolio Exits
1 Portfolio Exit
Alfred I. duPont Testamentary Trust has 1 portfolio exit. Their latest portfolio exit was La Jolla Pharmaceutical Company on February 06, 2006.
Date | Exit | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Acquirer | Sources |
|---|---|---|---|---|---|
2/6/2006 | IPO |
Date | 2/6/2006 |
|---|---|
Exit | IPO |
Companies | |
Valuation | |
Acquirer | |
Sources |
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.